Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptakeiInhibitor treatment / Susan G. Ball en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.5 (Mayo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 635–642 Título : Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptakeiInhibitor treatment Tipo de documento: texto impreso Autores: Susan G. Ball, Autor ; Margaret B. Ferguson, Autor ; James M. Martinez, Autor Fecha de publicación: 2020 Artículo en la página: pp. 635–642 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Terapia Combinada, Inhibidores de la captación de serotonina. Resumen: Three studies examined whether edivoxetine (a highly selective norepinephrine reuptake inhibitor) had efficacy as adjunctive therapy for patients with major depressive disorder (DSM-IV-TR) who were partial responders to selective serotonin reuptake inhibitor (SSRI) treatment of at least 6 weeks’ duration. Link: ./index.php?lvl=notice_display&id=21738 [artículo] Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptakeiInhibitor treatment [texto impreso] / Susan G. Ball, Autor ; Margaret B. Ferguson, Autor ; James M. Martinez, Autor . - 2020 . - pp. 635–642. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 635–642 Palabras clave: Trastorno depresivo mayor, Terapia Combinada, Inhibidores de la captación de serotonina. Resumen: Three studies examined whether edivoxetine (a highly selective norepinephrine reuptake inhibitor) had efficacy as adjunctive therapy for patients with major depressive disorder (DSM-IV-TR) who were partial responders to selective serotonin reuptake inhibitor (SSRI) treatment of at least 6 weeks’ duration. Link: ./index.php?lvl=notice_display&id=21738

---

1 (1 - 1 / 1)